Royal Philips, along with its consortium partners, has received funding from the EU’s Horizon 2020 program to pilot big data solutions to achieve better patient outcomes in healthcare at a lower cost.
The three-year program is the largest EU-funded initiative to transform the region’s healthcare sector through the use of big data.
The ‘BigMedilytics’ [2] program aims to improve patient outcomes and increase productivity in the health sector by applying Artificial Intelligence (AI) technologies to complex datasets across the data value chain. This includes data from patients, healthcare providers, health insurers and medical technology providers.
Philips Reserch head and chief technology officer Henk van Houten said: "From patients capturing their own health data with wearable devices to ubiquitous monitoring across the hospital from the emergency room to the general ward, a huge amount of information about people’s health is being created.
"By applying AI to that data and combining that with clinical knowledge we are able to develop meaningful insights and workflow improvements that can improve patient care whilst reducing the burden of cost to health systems."
By bringing together all the key players from across health data value chains, the program seeks to break down the barriers between traditional healthcare silos and combine data sources to unlock new insights and enable collaborative innovation.
It will also ensure the security and privacy of personal data is protected and managed within national and EU regulatory frameworks.
With funding shared across 35 partners in 12 countries, the collaboration will combine insights from more than 11 million patients. It will be divided into three areas: Population Health and Chronic Disease Management, Oncology, and the Industrialization of Healthcare.
With the majority of health budgets currently spent on treatment, the program will also implement pilots across the care continuum, from prevention to diagnosis, and treatment to home care.
Partners in the program include healthcare providers, technology companies, insurers, pharma, SMEs, research institutes and universities.
Source: Company Press Release